Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$18.22 -0.58 (-3.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Liabilities and Shareholders Equity (2015 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Liabilities and Shareholders Equity of $703.65 million in Q2 2026, up 18.0% from $596.15 million a year earlier and up 48.9% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends

At the end of FY2025, Syndax Pharmaceuticals reported Liabilities and Shareholders Equity of $529.71 million, down 26.9% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 12.0% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $724.82 million in FY2024 (+18.3%), $612.88 million in FY2023 (+23.3%), $497.24 million in FY2022 (+10.6%) and $449.66 million in FY2021 (+49.6%).
  • The Q2 2026 figure is the highest quarterly Liabilities and Shareholders Equity since Q4 2024.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in six of the last eight quarters, with growth averaging 7.8%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 54.5% in Q2 2022, against a decline of 26.9% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $472.67 million (Q1 2026), $529.71 million (Q4 2025) and $551.79 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Syndax Pharmaceuticals 1.68 Bn -53.94 Mn 69.58 Mn 703.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 703.65 Mn
Mar 31, 2026 472.67 Mn
Dec 31, 2025 529.71 Mn
Sep 30, 2025 551.79 Mn
Jun 30, 2025 596.15 Mn
Mar 31, 2025 640.71 Mn
Dec 31, 2024 724.82 Mn
Sep 30, 2024 425.81 Mn
Jun 30, 2024 476.95 Mn
Mar 31, 2024 543.03 Mn
Dec 31, 2023 612.88 Mn
Sep 30, 2023 399.22 Mn
Jun 30, 2023 431.34 Mn
Mar 31, 2023 459.83 Mn
Dec 31, 2022 497.24 Mn
Sep 30, 2022 359.69 Mn
Jun 30, 2022 406.44 Mn
Mar 31, 2022 422.22 Mn
Dec 31, 2021 449.66 Mn
Sep 30, 2021 239.50 Mn
API Access

Syndax Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SNDX&period=max&api_key=YOUR_API_KEY